JAMA Oncology

JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Publisher
JAMA
Website
http://oncology.jamanetwork.com/journal.aspx

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Blood cancer precursor found in 9/11 firefighters

A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead ...

Oncology & Cancer

Study finds association between high insulin dosage and cancer

Dr. Yuanjie Mao has led a study published in JAMA Oncology looking at the correlation between daily insulin dose and cancer incidence (the number of new cases) among patients with type 1 diabetes, finding that higher insulin ...

Oncology & Cancer

Breast cancer vaccine safely generates anti-tumor immunity

An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...

Oncology & Cancer

High BMI may improve cancer survival

Above average or high BMI—often linked to cancers, diabetes, cardiovascular and other diseases—may in some cases improve the chance of survival among certain cancers, new research from Flinders University indicates.

Oncology & Cancer

Is there a link between telomere length and cancer?

Telomeres are regions of repetitive DNA at the end of human chromosomes, which protect the end of the chromosome from damage. Whilst shorter telomeres are hypothesized biological markers of older age and have been linked ...

Oncology & Cancer

MRI may lower breast cancer deaths from variants in 3 genes

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a comparative modeling analysis to be published ...

page 1 from 40